NF1 mRNA biogenesis: Effect of the genomic milieu in splicing regulation of the NF1 exon 37 region

FEBS Letters

Volumn 580, Issue 18, 2006, Pages 4449-4456

  Baralle, Marco ^a   Skoko, Natasa ^a   Knezevich, Anna ^a   De Conti, Laura ^a   Motti, Dario ^a   Bhuvanagiri, Madhuri ^a   Baralle, Diana ^b   Buratti, Emanuele ^a   Baralle, Francisco E ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Exonic splicing enhancers; Genomic context; NF1; Splicing

Indexed keywords

MESSENGER RNA; NEUROFIBROMIN;

ARTICLE; BIOGENESIS; CODON; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; RNA PROCESSING; RNA SPLICING;

ALTERNATIVE SPLICING; EXONS; GENOMICS; HELA CELLS; HUMANS; NEUROFIBROMATOSIS 1; POINT MUTATION; REGULATORY SEQUENCES, RIBONUCLEIC ACID; RNA SPLICE SITES; RNA, MESSENGER;

EID: 33746354005     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.07.018     Document Type: Article

References (29)

1. Graveley B.R. Sorting out the complexity of SR protein functions. Rna 6 (2000) 1197-1211
2. Reed R. Mechanisms of fidelity in pre-mRNA splicing. Curr. Opin. Cell Biol. 12 (2000) 340-345
3. Smith C.W., and Valcarcel J. Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem. Sci. 25 (2000) 381-388
4. Proudfoot N.J., Furger A., and Dye M.J. Integrating mRNA processing with transcription. Cell 108 (2002) 501-512
5. Buratti E., and Baralle F.E. Another step forward for SELEXive splicing. Trends Mol. Med. 11 (2005) 5-9
6. Ars E., Serra E., Garcia J., Kruyer H., Gaona A., Lazaro C., and Estivill X. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum. Mol. Genet. 9 (2000) 237-247
7. Mattocks C., Baralle D., Tarpey P., Ffrench-Constant C., Bobrow M., and Whittaker J. Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain. J. Med. Genet. 41 (2004) e48
8. Messiaen L.M., Callens T., Mortier G., Beysen D., Vandenbroucke I., Van Roy N., Speleman F., and Paepe A.D. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum. Mutat. 15 (2000) 541-555
9. Whittaker J.L., Mattocks C., Baralle D., Tarpey P., Ffrench-Constant C., and Bobrow M. Re: Pitfalls of automated comparative sequence analysis as a single platform for routine clinical testing for NF1 (Messiaen and Wimmer). J. Med. Genet. 42 (2005) e41
10. Messiaen L., Callens T., De Paepe A., Craen M., and Mortier G. Characterisation of two different nonsense mutations, C6792A and C6792G, causing skipping of exon 37 in the NF1 gene. Hum. Genet. 101 (1997) 75-80
11. Wang J., Hamilton J.I., Carter M.S., Li S., and Wilkinson M.F. Alternatively spliced TCR RNA induced by disruption of reading frame. Science 297 (2002) 108-110
12. Wang J., Chang Y.F., Hamilton J.I., and Wilkinson M.F. Nonsense-associated altered splicing: a frame-dependent response distinct from nonsense-mediated decay. Mol. Cell 10 (2002) 951-957
13. Buhler M., and Muhlemann O. Alternative splicing induced by nonsense mutations in the immunoglobulin mu VDJ exon is independent of truncation of the open reading frame. Rna 11 (2005) 139-146
14. Hoffmeyer S., Nurnberg P., Ritter H., Fahsold R., Leistner W., Kaufmann D., and Krone W. Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors. Am. J. Hum. Genet. 62 (1998) 269-277
15. Zatkova A., Messiaen L., Vandenbroucke I., Wieser R., Fonatsch C., Krainer A.R., and Wimmer K. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1. Hum. Mutat. 24 (2004) 491-501
16. Pagani F., et al. Splicing factors induce Cystic Fibrosis Transmembrane Regulator exon 9 skipping through a non-evolutionary conserved intronic element. J. Biol. Chem. 275 (2000) 21041-21047
17. Baralle M., Baralle D., De Conti L., Mattocks C., Whittaker J., Knezevich A., Ffrench-Constant C., and Baralle F.E. Identification of a mutation that perturbs NF1, a gene splicing using genomic DNA samples and a minigene assay. J. Med. Genet. 40 (2003) 220-222
18. Pagani F., Buratti E., Stuani C., Bendix R., Dork T., and Baralle F.E. A new type of mutation causes a splicing defect in ATM. Nat. Genet. 30 (2002) 426-429
19. Pagani F., Stuani C., Tzetis M., Kanavakis E., Efthymiadou A., Doudounakis S., Casals T., and Baralle F.E. New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12. Hum. Mol. Genet. 12 (2003) 1111-1120
20. Vandenbroucke I., Callens T., De Paepe A., and Messiaen L. Complex splicing pattern generates great diversity in human NF1 transcripts. BMC Genomics 3 (2002) 13
21. Fang L.J., Simard M.J., Vidaud D., Assouline B., Lemieux B., Vidaud M., Chabot B., and Thirion J.P. A novel mutation in the neurofibromatosis type 1 (NF1) gene promotes skipping of two exons by preventing exon definition. J. Mol. Biol. 307 (2001) 1261-1270
22. Haire R.N., Ohta Y., Strong S.J., Litman R.T., Liu Y., Prchal J.T., Cooper M.D., and Litman G.W. Unusual patterns of exon skipping in Bruton tyrosine kinase are associated with mutations involving the intron 17 3′ splice site. Am. J. Hum. Genet. 60 (1997) 798-807
23. Schneider S., Wildhardt G., Ludwig R., and Royer-Pokora B. Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations. Hum. Genet. 91 (1993) 599-604
24. Fairbrother W.G., Yeh R.F., Sharp P.A., and Burge C.B. Predictive identification of exonic splicing enhancers in human genes. Science 297 (2002) 1007-1013
25. Stickeler E., Fraser S.D., Honig A., Chen A.L., Berget S.M., and Cooper T.A. The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4. Embo. J. 20 (2001) 3821-3830
26. Romano M., Marcucci R., and Baralle F.E. Splicing of constitutive upstream introns is essential for the recognition of intra-exonic suboptimal splice sites in the thrombopoietin gene. Nucleic Acids Res. 29 (2001) 886-894
27. Fededa J.P., et al. A polar mechanism coordinates different regions of alternative splicing within a single gene. Mol. Cell 19 (2005) 393-404
28. Pagani F., Raponi M., and Baralle F.E. Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution. Proc. Natl. Acad. Sci. USA 102 (2005) 6368-6372
29. Pagani F., Buratti E., Stuani C., and Baralle F.E. Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9. J. Biol. Chem. 278 (2003) 26580-26588